Charles M. Lieber, once a marquee name in American nanoscience, has quietly put a brain–computer research operation back together inside Shenzhen’s state backed science network. The new setup puts him at the helm of i‑BRAIN, an institute that pairs nanofabrication tools with a nearby primate research complex. For U.S. observers, the move highlights recurring tensions between academic openness and national security controls over dual use technologies.
As reported by Reuters, Lieber, who was convicted in 2021 of making false statements about his ties to China’s Thousand Talents program, is now overseeing the Institute for Brain Research, Advanced Interfaces and Neurotechnologies (i‑BRAIN) at the Shenzhen Medical Academy of Research and Translation (SMART). According to Reuters, the appointment gives him access to dedicated nanofabrication equipment and primate research infrastructure that he did not have at Harvard. At a Shenzhen government conference, Lieber said he “arrived on April 28, 2025 with a dream,” the outlet reported.
i‑BRAIN’s website notes that the lab took delivery of a deep ultraviolet lithography machine made by ASML in February, equipment the institute says will speed fabrication of high density neural probes. As detailed on i‑BRAIN, the institute combines nanofab, electronics and wet lab facilities in order to move designs toward prototype more quickly.
i‑BRAIN occupies renovated lab space on a SMART campus that sits next to a larger regional hub for brain science. The nearby Shenzhen Brain Science Infrastructure (BSI) says it maintains roughly 2,000 non human primate cages along with dedicated surgical and recovery suites. According to BSI, those resources are intended to support large scale translational work that many U.S. labs find difficult to sustain.
According to a U.S. Department of Justice press release, Lieber was convicted in December 2021 and sentenced in April 2023 to time served (two days), two years of supervised release that included six months of home confinement, a $50,000 fine and $33,600 in restitution. The DOJ notes that the Lieber Research Group conducted more than $15 million in U.S. government sponsored research between 2008 and 2019.
Policy Clash: Openness Vs. Security
Analysts say Lieber’s fast reconstitution of a lab in China underlines the strain between open academic collaboration and the strategic risks of dual use research. The elevation of brain computer interfaces in Beijing’s planning documents has figured prominently in recent policy assessments of the 2026 to 2030 planning cycle. According to MERICS, the new five year agenda explicitly lists BCI among prioritized technologies that Beijing intends to develop.
Harvard Ties And The Local Picture
Harvard wound down its New England Primate Research Center by 2015, a closure that reduced domestic capacity for large scale primate work and, in the view of some researchers, made overseas facilities more attractive. The Boston Globe covered the university’s decision and the subsequent wind down.
Back in Shenzhen, SMART and i‑BRAIN have been actively recruiting international talent and hosting visiting delegations, with documentation appearing on SMART’s pages and in i‑BRAIN’s recruitment notices. SMART hosted a Max Planck Society delegation in April, and i‑BRAIN’s site advertises openings for postdocs and researchers in non human primate electrophysiology. (SMART; i‑BRAIN.)
Legal Implications
Lieber’s conviction and sentence were relatively light in terms of prison time, and reporting plus court filings show he obtained permission while under supervised release to travel to China for approved purposes, a detail that has fueled debate about how far criminal penalties can go in curbing technical transfer. Court records and reporting indicate that judges authorized multiple travel requests in 2024 even as critics warned this undercuts deterrence. As reported by Reuters, some analysts call Lieber “Exhibit A” for how U.S. legal tools have struggled to deter transfers of talent and know how.
What to watch next: whether U.S. agencies tighten export or personnel controls, whether i‑BRAIN publishes translational results that move toward human trials, and whether universities and funders re assess collaborations with research centers embedded in state led innovation hubs. For now, Lieber’s Shenzhen lab stands as a vivid example of how the global race for brain computer interfaces is sharpening policy trade offs between openness and strategic competition.
